Answers are grounded in this paper and cite their sources.
Fungal infections have been growing as a major cause of morbidity and mortality among critically ill patients, usually within ICUs, whose mortality rates are often higher than those with bacterial infections. These critically ill patients, many of whom are immunocompromised and suffering from various comorbidities, tend to become highly susceptible to fungal infection. This predisposition has been exacerbated by extended hospitalization, profound use of antibiotics, and failure of multi-organ body systems. The current review represents an overview of fungal infections in the critical care setting, with a broad aspect toward Aspergillus , Candida , and Mucor . Various risk factors were discussed for the development of fungal infection, which ranged from immunosuppression to exposures related to healthcare settings. Diagnostic approaches were reviewed, ranging from conventional culture-based methods to modern molecular assays, and similarly, various emerging prognostic markers were presented. With the continued evolution of antifungal therapies, timely and appropriate diagnosis is paramount for improved prognosis of patients in the intensive care unit. This study will, therefore, arm healthcare professionals with the knowledge and tools required for the management of fungal infections in the critical care environment, ultimately improvement of quality of patient care, and survival rate.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: